Valens is trading 6% down at $1.80 after investors reacted negatively to the company's disappointing Q2 outlook.

  • The company projected Q2 revenue below analyst expectations and signaled an adjusted EBITDA loss.
  • Sentiment is pressured by marginal revenue growth and a previous quarterly loss, leaving the stock vulnerable.
  • The decline comes amid a broader pullback across the semiconductor sector.